candesartan has been researched along with Hypertension, Pregnancy-Induced in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hypertension, Pregnancy-Induced: A condition in pregnant women with elevated systolic (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gestational hypertension was markedly improved by treatment of Candesartan compared with the control." | 5.48 | Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway. ( Wang, X; Zhao, X, 2018) |
| "Gestational hypertension was markedly improved by treatment of Candesartan compared with the control." | 1.48 | Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway. ( Wang, X; Zhao, X, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, X | 1 |
| Wang, X | 1 |
| Ishii, M | 1 |
| Hattori, A | 1 |
| Numaguchi, Y | 1 |
| Ma, X | 1 |
| Nagasaka, T | 1 |
| Tsujimoto, M | 1 |
| Murohara, T | 1 |
| Kobayashi, H | 1 |
| Mizutani, S | 1 |
| Hünseler, C | 1 |
| Paneitz, A | 1 |
| Friedrich, D | 1 |
| Lindner, U | 1 |
| Oberthuer, A | 1 |
| Körber, F | 1 |
| Schmitt, K | 1 |
| Welzing, L | 1 |
| Müller, A | 1 |
| Herkenrath, P | 1 |
| Hoppe, B | 1 |
| Gortner, L | 1 |
| Roth, B | 1 |
| Kattner, E | 1 |
| Schaible, T | 1 |
3 other studies available for candesartan and Hypertension, Pregnancy-Induced
| Article | Year |
|---|---|
Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Endothelial Cells; Female; Humans; Hypertension, Pregna | 2018 |
The effect of recombinant aminopeptidase A (APA) on hypertension in pregnant spontaneously hypertensive rats (SHRs).
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 2009 |
Angiotensin II receptor blocker induced fetopathy: 7 cases.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents | 2011 |